⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13072244 | 0.81 | — | — | |
| SCHEMBL3576045 | 0.75 | ALDH1A1 (0.39) | — | |
| SCHEMBL4537742 | 0.72 | DUT (0.49) | — | |
| SCHEMBL6675403 | 0.70 | CYP3A4 (0.52) | — | |
| SCHEMBL3629435 | 0.70 | ALDH1A1 (0.43) | — | |
| SCHEMBL4448355 | 0.68 | — | — | |
| SCHEMBL128380 | 0.68 | CYP3A4 (0.45) | — | |
| SCHEMBL3425729 | 0.67 | — | — | |
| SCHEMBL13584600 | 0.65 | KMT2A (0.40) | — | |
| SCHEMBL18097097 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3193849-A1 | OPIPRAMOL PATCH | Neuroderm, Ltd. (IL) | 2017-07-26 | — | — | EP | claimed |
| WO-2016042413-A1 | OPIPRAMOL PATCH | NEURODERM, LTD. (IL) | 2016-03-24 | — | — | WO | claimed |
| US-7879344-B2 | contains antiitch agent; for use in wipes and absorbent articles, and transdermal patches | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2011-02-01 | — | — | US | claimed |
| EP-2040693-A2 | TRANSDERMAL DELIVERY OF OLEOCANTHAL FOR RELIEF OF INFLAMMATION | Kimberly-Clark Worldwide, Inc. (US) | 2009-04-01 | — | — | EP | claimed |
| US-20080003273-A1 | Transdermal Delivery of Oleocanthal for Relief of Inflammation | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2008-01-03 | — | — | US | claimed |
| WO-2008001240-A2 | TRANSDERMAL DELIVERY OF OLEOCANTHAL FOR RELIEF OF INFLAMMATION | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2008-01-03 | — | — | WO | claimed |
| EP-0813879-B1 | Drug administration composition for iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 2002-10-30 | — | — | EP | claimed |
| US-20240180922-A1 | TREATMENTS FOR DIABETIC NEUROPATHY | UNIV MANITOBA (CA) | 2024-06-06 | — | — | US | disclosed |
| US-20240166596-A1 | SULFAMOYL BENZENE DERIVATIVES AND USES THEREOF | APHIOTX INC (CA) | 2024-05-23 | — | — | US | disclosed |
| EP-4370502-A1 | SULFAMOYL BENZENE DERIVATIVES AND USES THEREOF | AphioTx Inc. (CA) | 2024-05-22 | — | — | EP | disclosed |
| US-20240108648-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2024-04-04 | — | — | US | disclosed |
| WO-2024072942-A2 | SKIN PENETRATING FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA ANIMAL HEALTH CORPORATION (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4333802-A1 | WOUND TREATMENT COMPOSITION | CS Medica A/S (DK) | 2024-03-13 | — | — | EP | disclosed |
| EP-0989845-A1 | TOPICAL ADMINISTRATION OF CATECHOLAMINES AND RELATED COMPOUNDS TO SUBCUTANEOUS MUSCLE TISSUE USING PERCUTANEOUS PENETRATION ENHANCERS | PERRICONE, Nicholas V (US) | 2000-04-05 | — | — | EP | disclosed |
| US-5908400-A | DRUG DELIVERY | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1999-06-01 | — | — | US | disclosed |
| US-5879690-A | Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers | N.V. PERRICONE LLC | 1999-03-09 | — | — | US | disclosed |
| WO-1998050014-A1 | TOPICAL ADMINISTRATION OF CATECHOLAMINES AND RELATED COMPOUNDS TO SUBCUTANEOUS MUSCLE TISSUE USING PERCUTANEOUS PENETRATION ENHANCERS | PERRICONE NICHOLAS V (US) | 1998-11-12 | — | — | WO | disclosed |
| EP-0813887-A2 | A device structure for iontophoresis | HISAMITSU PHARMACEUTICAL CO. INC. (JP) | 1997-12-29 | — | — | EP | disclosed |
| EP-0813879-A2 | Drug administration composition for iontophoresis | HISAMITSU PHARMACEUTICAL CO. INC. (JP) | 1997-12-29 | — | — | EP | disclosed |
| US-4845233-A | TOPICAL PENETRATION ENHANCER FOR PHYSIOLOGICALLY ACTIVE AGENTS | IPRX, INC. (US) | 1989-07-04 | — | — | US | disclosed |